opdualag (nivolumab and relatlimab-rmbw)- metastatic melanoma
Published 9 months ago • 144 plays • Length 1:49Download video MP4
Download video MP3
Similar videos
-
6:19
should you treat melanoma with nivolumab and relatlimab (opdualag)?
-
0:46
the benefits of nivolumab and relatlimab in melanoma
-
6:17
relativity-047: relatlimab, an anti-lag-3 antibody nivolumab in first-line advanced melanoma
-
1:56
2-yr relativity-047: nivolumab relatlimab in previously untreated metastatic/unresectable melanoma
-
6:21
new long-term data 'clearly favor' combination ipilimumab/nivolumab in melanoma
-
1:03
dr. long on nivolumab/ipilimumab in patients with melanoma brain metastases
-
2:10
ipilimumab combined with nivolumab for patients with melanoma
-
1:02
dr. danae delivanis pembrolizumab and nivolumab in metastatic melanoma
-
1:24
dr. ernstoff discusses nivolumab and ipilimumab in advanced melanoma
-
1:12
current trials in the treatment of melanoma
-
42:49
clonal evolution underlying transplacental transmission and vemurafenib resistance in melanoma
-
47:39
evolution of metastatic melanoma: insights from a post-mortem study
-
27:45
advances in the surgical management of melanoma
-
29:04
melanoma update
-
1:04
melanoma treatment options clinical trials
-
11:40
aim at melanoma - melanoma: introduction to evolution, diagnosis & treatment
-
4:44
when genomics collides with melanoma
-
27:32
melanoma and the immune response
-
1:30
dr. jason luke discusses nivolumab and pembrolizumab in melanoma